The levels of GFAP and of antibodies against NR2 RNMDA assessed within 12 hrs after the onset of symptoms could be used to identify the type of stroke (IS or ICH) with a discriminant function – binary logit regression (see Table2). This evidence concerns the gene GFAP and stroke disorder.